Elekta AB Receivables 2013-2024 | EKTAY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Elekta AB receivables from 2013 to 2024. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Elekta AB receivables from 2013 to 2024. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$211B
Intuitive Surgical (ISRG)	$191.1B
Alcon (ALC)	$45.7B
IQVIA Holdings (IQV)	$39.8B
Edwards Lifesciences (EW)	$39.1B
IDEXX Laboratories (IDXX)	$35.5B
DexCom (DXCM)	$27.3B
Waters (WAT)	$22.8B
SONOVA HOLDING (SONVY)	$22.1B
STERIS (STE)	$21.6B
Hologic (HOLX)	$18.3B
Sysmex ADR (SSMXY)	$12.9B
Fresenius Medical Care AG KGaA (FMS)	$12.5B
Globus Medical (GMED)	$11B
Teleflex (TFX)	$9.1B
Penumbra (PEN)	$9.1B
Masimo (MASI)	$8.7B
Glaukos (GKOS)	$7.8B
PROCEPT BioRobotics (PRCT)	$5.2B
Integer Holdings (ITGR)	$4.6B
Inari Medical (NARI)	$3B
TransMedics (TMDX)	$2.9B
LivaNova (LIVN)	$2.8B
Veracyte (VCYT)	$2.8B
Nihon Kohden (NHNKY)	$2.6B
Tandem Diabetes Care (TNDM)	$2B
Integra LifeSciences Holdings (IART)	$1.9B
RxSight (RXST)	$1.8B
Alphatec Holdings (ATEC)	$1.3B
Pulse Biosciences (PLSE)	$1.2B